• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: A randomized, double-blind, placebo-controlled pilot trial.

作者信息

Chong Sharene, Wong Ho Yi, Althabteh Ahmad, Cox Charlotte, Stevenson Paul H, Brown Susan, Griffin Anthony, Isbel Nicole, Siller Gregory, Soyer H Peter, Schaider Helmut, Roy Edwige, Campbell Scott, Green Adele C, Khosrotehrani Kiarash

机构信息

University of Queensland, UQ Diamantina Institute, Experimental Dermatology Group, Brisbane, Australia.

University of Queensland, UQ Diamantina Institute, Experimental Dermatology Group, Brisbane, Australia; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia.

出版信息

J Am Acad Dermatol. 2022 Nov;87(5):1163-1166. doi: 10.1016/j.jaad.2022.02.039. Epub 2022 Feb 25.

DOI:10.1016/j.jaad.2022.02.039
PMID:35219749
Abstract
摘要

相似文献

1
Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: A randomized, double-blind, placebo-controlled pilot trial.使用局部西罗莫司对实体器官移植受者皮肤鳞状细胞癌及其前驱病变进行化学预防：一项随机、双盲、安慰剂对照的试点试验。
J Am Acad Dermatol. 2022 Nov;87(5):1163-1166. doi: 10.1016/j.jaad.2022.02.039. Epub 2022 Feb 25.
2
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.烟酰胺用于预防移植受者的皮肤癌。
N Engl J Med. 2023 Mar 2;388(9):804-812. doi: 10.1056/NEJMoa2203086.
3
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).器官移植受者光化性角化病的局部治疗：SPOT（使用局部治疗预防器官移植受者鳞状细胞癌）的可行性研究。
Br J Dermatol. 2022 Sep;187(3):324-337. doi: 10.1111/bjd.20974. Epub 2022 Jun 14.
4
Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.实体器官移植受者中角质形成细胞癌和光化性角化病的化学预防：系统评价和荟萃分析。
J Am Acad Dermatol. 2021 Feb;84(2):528-530. doi: 10.1016/j.jaad.2020.04.160. Epub 2020 May 5.
5
Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.氟尿嘧啶 5%乳膏单次疗程用于基底细胞和鳞状细胞癌的化学预防：一项随机临床试验。
JAMA Dermatol. 2018 Feb 1;154(2):167-174. doi: 10.1001/jamadermatol.2017.3631.
6
The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.西罗莫司在预防器官移植受者皮肤鳞状细胞癌中的作用。
Dermatol Surg. 2011 Jun;37(6):744-9. doi: 10.1111/j.1524-4725.2011.01973..x.
7
Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.卡培他滨治疗和预防光化性角化病、鳞状细胞癌和基底细胞癌的应用评价：系统评价。
JAMA Dermatol. 2020 Oct 1;156(10):1117-1124. doi: 10.1001/jamadermatol.2020.2327.
8
Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.全身及局部使用维甲酸类药物治疗器官移植受者的皮肤癌
Dermatol Surg. 2004 Apr;30(4 Pt 2):656-61. doi: 10.1111/j.1524-4725.2004.30152.x.
9
Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey.口服维甲酸用于器官移植受者皮肤癌的化学预防：一项调查结果
Transplant Proc. 2006 Jun;38(5):1366-8. doi: 10.1016/j.transproceed.2006.02.119.
10
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.塞来昔布预防非黑素瘤皮肤癌的随机、双盲、安慰剂对照试验。
J Natl Cancer Inst. 2010 Dec 15;102(24):1835-44. doi: 10.1093/jnci/djq442. Epub 2010 Nov 29.

引用本文的文献

1
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention.免疫检查点抑制剂在场癌化及角质形成细胞癌预防中的应用
JAMA Dermatol. 2025 Apr 1;161(4):383-390. doi: 10.1001/jamadermatol.2024.5750.
2
Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients.西罗肤美：一项随机双盲安慰剂对照研究，评估外用西罗莫司预防实体器官移植受者面部鳞状细胞癌的临床试验方案。
Trials. 2024 Nov 22;25(1):789. doi: 10.1186/s13063-024-08619-3.
3
Assessment of Mammalian Target of Rapamycin Pathway Activation in Basal Cell Carcinoma as a New Therapeutic Approach.
评估哺乳动物雷帕霉素靶蛋白通路在基底细胞癌中的激活作为一种新的治疗方法。
Am J Dermatopathol. 2024 Sep 1;46(9):588-592. doi: 10.1097/DAD.0000000000002718. Epub 2024 Apr 23.
4
Predicting Tacrolimus Concentrations in the Skin of Adult Kidney Transplant Recipients: A Feasibility Study.预测成人肾移植受者皮肤中环孢素浓度：一项可行性研究。
Transpl Int. 2024 Jan 23;37:12019. doi: 10.3389/ti.2024.12019. eCollection 2024.
5
Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.实体器官移植受者皮肤鳞状细胞癌的预后结果：一项回顾性比较队列研究。
J Clin Med. 2023 Dec 11;12(24):7619. doi: 10.3390/jcm12247619.